Ikarovec - Crunchbase Company Profile & Funding

Q: Who invested in Ikarovec?

Ikarovec has 5 investors including LifeArc Ventures And UK Innovation & Science Seed Fund.

Q: When was the last funding round for Ikarovec?

Ikarovec closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Ikarovec raised to date?

Ikarovec has raised obfuscated.

Overview

Ikarovec

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ikarovec

CB Rank

70962

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Founded

obfuscation

Private

Seed

Cambridge, Cambridgeshire, United Kingdom

1-10

ikarovec.com/

Biotechnology

Health Care

Life Science

Funding Rounds

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Peter Widdowson: Founder, Director and Chief Technology Officer
Katie Binley: Chief Scientific Officer

Details

Legal Name

Ikarovec Limited

Operating Status

Active

Company Type

For Profit

Founders

Peter Widdowson

About the Company

Ikarovec is developing novel gene therapies to treat major ophthalmic indications.

Predictions & Insights

Growth Insight

See this Growth Insight

Ikarovec is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Gene Therapy for Diabetic Macular Edema

A gene therapy treatment designed to address diabetic macular edema by introducing DNA into target cells in the eye to produce therapeutic proteins.

Gene Therapy for Geographic Atrophy

A gene therapy aimed at treating geographic atrophy, an advanced form of age-related macular degeneration, by using adeno-associated viral vectors to deliver therapeutic genes.

Research & Development

Ikarovec is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed
obfuscated obfuscation	Seed Round - Ikarovec	4	obfuscated obfuscation	LifeArc Ventures, Parkwalk Advisors	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
LifeArc Ventures	Yes	Seed Round - Ikarovec	David Holbrook
LifeArc Ventures	Yes	Seed Round - Ikarovec	David Holbrook
LifeArc Ventures	Yes	Seed Round - Ikarovec	David Holbrook
LifeArc Ventures	Yes	Seed Round - Ikarovec	David Holbrook
LifeArc Ventures	Yes	Seed Round - Ikarovec	David Holbrook